Skip to content

Pilot Evaluation of the FilmArray® Childhood Systemic Infection (CSI) Panel

Pilot Evaluation of the FilmArray® Childhood Systemic Infection (CSI) Panel

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03064100
Enrollment
1500
Registered
2017-02-24
Start date
2017-03-21
Completion date
2018-02-28
Last updated
2017-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Infection

Brief summary

The purpose of this study is to collect data to support decisions made by BioFire regarding assay development, panel composition, and intended use for the final FilmArray CSI reagent pouch. The study will utilize whole blood and/or plasma obtained from pediatric patients under 18 years of age that present with acute fever.

Interventions

OTHERObservational Study

Exclusion from the study

Sponsors

BioFire Diagnostics, LLC
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 17 Years
Healthy volunteers
No

Inclusion criteria

* Subject has presented to the ED and is suspected of a systemic infection as indicated by a clinician order for blood culture * Parent/guardian gives written permission (and assent is obtained from children of sufficient maturity) * Blood specimen can be collected at the same time as the blood culture during the ED visit (or within 12 hours of being admitted from the ED) * Specimen is at least 500 µL (1.5 mL collection desired)

Exclusion criteria

* Parent/guardian is unavailable or unable to give permission, or assent is not obtained (from children of sufficient maturity) * Physician determines that participation in the study is an unacceptable health risk * Minimum volume requirement is not met

Design outcomes

Primary

MeasureTime frame
Sensitivity (or positive percent agreement) and specificity (or negative percent agreement) of the assays comprising FilmArray CSI Panel with respect to reference methods (bacterial culture and independent molecular assays)12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026